BioCentury This Week

Podcast1 episode summarized

MurmurCast publishes AI-generated summaries of BioCentury This Week’s Podcast episodes — 1 summarized so far, covering Moderna Phase 3 neoantigen vaccine win, Personalized medicine and manufacturing challenges, Genentech-Hanmi obesity deal, South Korean biotech companies, FDA independence and political influence, Heidi Overton nomination. Each summary distills the key insights, topics, and takeaways so you can decide what’s worth your time before pressing play.

Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick

19mAug 25, 2026

BioCentury discusses Moderna's major Phase 3 win with Merck in personalized neoantigen vaccines for melanoma, Genentech-Roche's obesity deal with Korean company Hanmi for a urocortin-2 analog, and concerns about FDA independence following the nomination of Trump loyalist Heidi Overton as FDA commissioner.

NewsDiscussionModerna Phase 3 neoantigen vaccine winPersonalized medicine and manufacturing challengesGenentech-Hanmi obesity deal

Get AI summaries like this delivered to your inbox daily